All stock lists
Kamada Ltd (NASDAQ:KMDA)
Israel · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
7.88+0.11 (+1.42%)
Insider Score
––Not scored
KMDA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KMDA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 54.92 M | 45.24 M | 44.68 M | 47.01 M | 44.75 M | 44.02 M |
| Revenue Growth (YoY) | 22.72 % | 2.78 % | 14.54 % | 12.63 % | 5.37 % | 16.65 % |
| Cost of Revenue | 32.45 M | 26.12 M | 27.71 M | 27.25 M | 25.82 M | 23.27 M |
| Gross Profit | 22.47 M | 19.12 M | 16.97 M | 19.76 M | 18.93 M | 20.75 M |
| SG&A Expense | 10.76 M | 9.98 M | 7.18 M | 9.32 M | 8.63 M | 8.71 M |
| R&D Expense | 2.20 M | 2.18 M | 2.89 M | 2.64 M | 3.22 M | 4.25 M |
| Operating Expenses | 12.96 M | 12.16 M | 13.42 M | 11.95 M | 11.86 M | 12.95 M |
| Operating Income | 9.51 M | 6.95 M | 3.55 M | 7.82 M | 7.07 M | 7.79 M |
| Pretax Income | 10.19 M | 5.39 M | 4.73 M | 6.37 M | 5.75 M | 6.61 M |
| Tax Provision | 927.00 K | 1.26 M | 1.17 M | 1.07 M | -1.62 M | 2.65 M |
| Net Income | 9.26 M | 4.13 M | 3.56 M | 5.30 M | 7.38 M | 3.96 M |
| EPS (Basic) | 0.16 | 0.07 | 0.06 | 0.09 | 0.13 | 0.07 |
| EPS (Diluted) | 0.16 | 0.07 | 0.06 | 0.09 | 0.13 | 0.07 |
| Shares Outstanding | 57.89 M | 59.03 M | 57.69 M | 58.84 M | 56.74 M | 56.63 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.